Home Treatment for Acute Psychiatric Care
Home Treatment for Acute Psychiatric Care in the Canton of Aargau (Switzerland): A Randomized Controlled Trial
This study aims to evaluate whether psychiatric home treatment is an effective and efficient alternative to acute inpatient care in mental hospitals. A one-year prevalence cohort of psychiatric patients in need of hospitalization are randomly assigned to either treatment at inpatient wards (treatment as usual) or a new care model with the additional option of treating patients at their homes by mobile care teams. The primary focus is on checking whether optional home treatment leads to a reduction of inpatient days during a two-year follow-up period. In addition, the two service models will be compared regarding treatment cost and outcomes as well as satisfaction of patients and their relatives with psychiatric care.
Furthermore, a sub-cohort of randomly chosen patients from the prevalence-cohort will be examined by a highly trained clinical assessor to test and verify the diagnoses and the clinical ratings made by the staff members of the mental hospital under routine everyday conditions.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
This study aims to evaluate whether psychiatric home treatment is an effective and efficient alternative to acute inpatient care in mental hospitals. A one-year prevalence cohort of psychiatric patients in need of hospitalization are randomly assigned to either treatment at inpatient wards (treatment as usual) or a new care model with the additional option of treating patients at their homes by mobile care teams. The primary focus is on checking whether optional home treatment for crisis intervention leads to a reduction of inpatient days during a two-year follow-up period. In addition, the two service models will be compared regarding treatment cost and outcomes as well as satisfaction of patients and their relatives with psychiatric care.
Furthermore, a sub-cohort of randomly chosen patients from the prevalence-cohort will be examined by a highly trained clinical assessor to test and verify the diagnoses (SCID-I and SCID-II) and the clinical ratings (HoNOS) made by the staff members of the mental hospital under routine everyday conditions.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Aargau
-
Brugg, Aargau, Switzerland, 5201
- Psychiatric Services Aargau AG
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Need for acute psychiatric inpatient care
- Residence in the canton of Aargau
- Living within 30 minutes (by car) from the headquarters of the home treatment team
- Health insurance with tarifsuisse
Exclusion Criteria:
- Insufficient proficiency in German
- Main diagnosis F0 or F1 (ICD-10)
- Patients of the forencic departement
- Patients of the child and adolescent department
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Home treatment
Patients in need of acute psychiatric inpatient care are treated at their houses by mobile treatment teams instead of treatment at mental hospitals whenever home treatment is possible and appropriate.
|
Patients are treated at home whenever possible and appropriate
|
|
ACTIVE_COMPARATOR: Treatment as usual
Patients in need of acute psychiatric inpatient care are treated at a mental hospital.
|
Patients are treated at a mental hospital
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of inpatient days
Time Frame: 2 years follow-up
|
2 years follow-up
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total days in treatment (inpatient + home treatment)
Time Frame: 2 years follow-up
|
2 years follow-up
|
|
|
Direct treatment costs
Time Frame: 2 years follow-up
|
2 years follow-up
|
|
|
Health of the Nation Outcome Scales (HoNOS)
Time Frame: Intake and discharge from treatment episode (expected average of 4 weeks)
|
Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
|
Intake and discharge from treatment episode (expected average of 4 weeks)
|
|
Brief Symptom Checklist (BSCL)
Time Frame: Intake and discharge from treatment episode (expected average of 4 weeks)
|
Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
|
Intake and discharge from treatment episode (expected average of 4 weeks)
|
|
Perceptions of Care-18
Time Frame: Discharge from treatment episode (expected average of 4 weeks)
|
Participants will be assessed at discharge from hospital, after an expected average of 4 weeks.
|
Discharge from treatment episode (expected average of 4 weeks)
|
|
Satisfaction of patients' relatives
Time Frame: Discharge from treatment episode (expected average of 4 weeks)
|
Relatives' satisfaction will be assessed with an adapted version of the Perceptions of Care-18 questionnaire at discharge of the patients from hospital, after an expected average of 4 weeks.
The proportion of satisfied relatives will be reported for both study arms.
|
Discharge from treatment episode (expected average of 4 weeks)
|
|
Number of rehospitalizations per patient
Time Frame: 2 years follow-up
|
2 years follow-up
|
|
|
Number of patients with adverse events
Time Frame: 2 years follow-up
|
E.g. suicide or attempted suicide.
|
2 years follow-up
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Niklaus Stulz, PhD, Psychiatric Services Aargau AG
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- PDAG-0001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.